financetom
Business
financetom
/
Business
/
Deutsche Bank on Restaurant Brands International's Q2
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank on Restaurant Brands International's Q2
Aug 8, 2025 11:40 AM

02:05 PM EDT, 08/08/2025 (MT Newswires) -- Restaurant Brands International reported a mixed second-quarter print with better-than-expected global SSS, while EBITDA/EPS modestly missed (in part due to timing of expenses), writes Deutsche Bank.

The company reiterated its 2025 guide for 8%+ organic AOI growth and ~3% unit growth, with both metrics to be more heavily weighted to the fourth quarter. Global SSS improved to 2.4%, with beats at Tim Hortons Canada (3.6%) and International (4.2%), while Burger King US was in-line (1.5%).

Momentum has continued into the fourth quarter as well, with Deutsche Bank expecting SSS to accelerate globally in the second half.

"We remain positive on QSR and believe several quarters of consistent execution and signs of underlying unit growth momentum should support better sentiment (against a low bar) and help narrow the valuation gap to peers (trading at 5-6x discount to MCD/YUM with a similar growth algorithm)," says analyst Lauren Silberman.

Restaurant Brands has a Buy rating and an US$82 price target.

Price: 89.47, Change: +0.01, Percent Change: +0.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved